Hypopnea is a condition involving a partial decrease in breathing during sleep. Airflow is not completely cut off, but drops by at least 30% and is usually accompanied by a decrease in blood oxygen levels.
It is generally accompanied by a decrease in blood oxygen levels or an arousal response (micro-arousal) along with a reduction in airflow lasting at least 10 seconds. Hypopnea is mostly evaluated as part of sleep apnea syndrome and is counted along with apneas when calculating the Apnea-Hypopnea Index (AHI). Although it may seem mild on its own, when it recurs frequently, it can seriously disrupt sleep quality.
Its symptoms include fragmented sleep throughout the night, waking up tired in the morning, headache, excessive daytime sleepiness, lack of attention, and difficulty concentrating. In some individuals, snoring, night sweats, and dry mouth may also occur. Hypopnea attacks are usually not noticed by the individual; they are most often investigated due to complaints of irregular breathing or snoring noticed by a partner.
What is Hypopnea?
Hypopnea is a condition where breathing during sleep does not completely stop, but rather significantly decreases. It is usually accompanied by a drop in blood flow lasting at least 10 seconds, along with a decrease in blood oxygen levels or a brief arousal reaction. It is evaluated as part of sleep apnea syndrome and, together with apneas, is included in the calculation of the Apnea-Hypopnea Index (AHI). When it recurs frequently, it can disrupt sleep quality and lead to complaints such as daytime fatigue and decreased attention.
Hypopnea mostly occurs due to partial narrowing of the upper airway and is most commonly seen together with obstructive sleep apnea. The person does not completely run out of breath, but breathing becomes shallow, and because the body does not receive enough oxygen, the brain sends a brief arousal signal. This condition can repeat multiple times throughout the night and disrupts sleep integrity without being noticed. In the long term, when left untreated, it can be associated with chronic fatigue, concentration problems, and an increased cardiovascular risk.
Definition of Hypopnea
Hypopnea is a respiratory event characterized by a significant decrease in airflow during sleep, rather than a complete cessation. According to polysomnographic criteria, it is typically associated with a decrease in airflow of at least 30% lasting for at least 10 seconds, accompanied by a drop in oxygen saturation (≥3%–4%) or an electroencephalographic arousal. Unlike apnea, ventilation does not completely stop; however, alveolar ventilation decreases, and intermittent hypoxemia may develop accordingly. Hypopneas, along with apneas, are included in the calculation of the Apnea-Hypopnea Index (AHI) and are considered one of the fundamental parameters in the diagnosis and severity classification of sleep-related breathing disorders.
Hypopnea events can develop due to obstructive or central mechanisms; in obstructive hypopnea, airflow decreases due to partial narrowing in the upper airway while respiratory effort continues, whereas in central hypopnea, a decrease in respiratory effort is also observed. Recurrent hypopneas can disrupt sleep architecture, leading to frequent micro-arousals, increased sympathetic activity, and a cardiovascular stress load. Therefore, in clinical evaluation, not only complete apneas, but also the frequency of hypopnea and the accompanying level of oxygen desaturation must be analyzed in detail.
Difference Between Apnea and Hypopnea
Apnea and hypopnea are breathing disorders seen during sleep, but there is a fundamental difference in severity between them. Apnea is the complete cessation of airflow for at least 10 seconds; hypopnea, on the other hand, is not a complete stoppage of breathing, but rather a significant decrease. While ventilation drops to zero in apnea, partial airflow continues in hypopnea, though an oxygen drop and micro-arousals may occur. Both conditions are evaluated together in the calculation of the Apnea-Hypopnea Index (AHI) and are used to determine the severity of sleep apnea. Although hypopnea may clinically appear milder, when it recurs frequently, it can produce physiological effects as severe as apnea.
From a physiological perspective, during apnea, both airflow ceases completely and—in certain types (such as central apnea)—respiratory effort can disappear; in hypopnea, although airflow is reduced, it does not completely disappear. While apneas generally cause a more pronounced drop in oxygen, hypopneas can lead to milder but more frequently recurring desaturations. Therefore, in clinical evaluation, not only complete respiratory stoppages, but also the frequency and duration of partial reductions are of great importance, as they together constitute the total respiratory disorder burden.
What is AHI (Apnea-Hypopnea Index)?
AHI (Apnea-Hypopnea Index) is a metric that expresses the total number of apnea and hypopnea events occurring within one hour during sleep. It is calculated during a sleep study (polysomnography) and is used as the primary criterion in determining the presence and severity of sleep apnea. While an AHI value below 5 is considered normal, 5–15 is classified as mild, 15–30 as moderate, and above 30 as severe sleep apnea. This index is an important parameter in determining the necessity of treatment and evaluating the effectiveness of the applied treatment.
While the AHI value alone is diagnostic, it is evaluated together with clinical symptoms and the level of oxygen desaturation. This is because in some patients, even if the AHI is at a moderate level, marked daytime sleepiness, cardiac arrhythmias, or severe oxygen drops may be observed. Furthermore, since AHI reflects an average value throughout sleep duration, the distribution of events (for example, showing an increase during REM sleep or concentration in the supine position) is also taken into consideration in treatment planning. Therefore, AHI is a fundamental clinical indicator for both the diagnosis and follow-up of sleep-related breathing disorders.
| AHI Value (Per Hour) | Severity Level | Clinical Evaluation |
|---|---|---|
| 0 – 4.9 | Normal | No clinically significant sleep apnea |
| 5 – 14.9 | Mild | Mild sleep apnea |
| 15 – 29.9 | Moderate | Moderate sleep apnea |
| 30 and above | Severe | Severe sleep apnea |
What Are the Symptoms of Hypopnea?
Hypopnea symptoms often develop unnoticed throughout the night, but they can significantly affect both sleep quality and daytime performance. Respiration becoming shallow and inadequate leads to a drop in blood oxygen levels and frequent micro-arousals. This situation can cause complaints such as waking up unrefreshed in the morning, headaches, and dry mouth. During the day, excessive sleepiness, fatigue, lack of attention, forgetfulness, and difficulty concentrating may be observed. In some individuals, snoring, night sweats, and restless sleep also accompany the clinical picture. Symptoms may present mildly, but when they persist for a long time, they can seriously affect the quality of life.
Hypopnea attacks are generally not noticed by the person himself; they usually come to light with irregular breathing and snoring complaints observed by a partner or family members. Oxygen drops repeating throughout the night can lead to fluctuations in heart rate and sleep fragmentation. In the long term, when left untreated, it can be associated with chronic fatigue, decreased work performance, and an increased cardiovascular risk. Therefore, a detailed evaluation is important, especially for individuals who wake up tired in the morning and experience unexplained daytime sleepiness.
What Causes Hypopnea?
Hypopnea generally occurs due to partial narrowing of the upper airway during sleep. The relaxation of throat muscles during sleep can cause not a complete closure of the airway, but a significant narrowing, which leads to breathing becoming shallow. The most frequent cause is anatomical narrowing associated with obstructive sleep apnea. Factors such as obesity, a thick neck circumference, tonsillar hypertrophy, a small jaw structure, and nasal congestion increase the risk.
More rarely, hypopnea can develop due to central nervous system-derived respiratory control disorders. In this case, the brain cannot send sufficient signals to the respiratory muscles, and respiratory depth decreases. Heart failure, neurological diseases, and certain medications (especially opioids and sedatives) may also play a role in the development of hypopnea. Additionally, alcohol consumption and the supine sleeping position can trigger hypopnea attacks by increasing airway resistance.
Obesity
Obesity is one of the most important risk factors for hypopnea and obstructive sleep apnea. The increase in adipose tissue around the neck and upper airway can cause the airway to narrow during sleep. Especially when lying in the supine position, this narrowing becomes more pronounced along with the relaxed throat muscles, and breathing becomes shallow. Furthermore, abdominal fat accumulation can restrict diaphragmatic movements and reduce lung capacity. While the frequency of hypopnea generally increases with weight gain, controlled weight loss can contribute to a reduction in respiratory events and an improvement in sleep quality.
Obesity can also negatively affect the cardiovascular system by increasing systemic inflammation and insulin resistance; this situation increases the burden of oxygen fluctuations occurring during sleep on the body. An increased body mass index (BMI) is directly correlated with rising Apnea-Hypopnea Index (AHI) values. Therefore, weight control is an important treatment step not only for general health, but also for reducing the severity of sleep-related breathing disorders. An appropriate nutritional plan and regular physical activity can contribute to a reduction in hypopnea attacks.
Upper Airway Narrowing
Upper airway narrowing is one of the most common causes of hypopnea and becomes pronounced with the relaxation of throat muscles during sleep. Instead of the complete closure of the airway, its partial narrowing leads to shallow breathing and decreased airflow. A small jaw structure, large tonsils, retropositioned tongue base, nasal congestion, or anatomical strictures can lay the groundwork for this condition. The narrowing airway, coupled with a decrease in muscle tone during sleep, can cause a drop in oxygen levels and micro-arousals, disrupting sleep quality.
Upper airway narrowing can become even more pronounced particularly in the supine position; under the effect of gravity, the tongue base and soft palate shift backward, narrowing the airway. Conditions affecting the nasal passage, such as allergic rhinitis, chronic sinusitis, or a deviated nasal septum, can also increase hypopnea attacks by reducing airflow. Therefore, anatomical evaluation and planning medical or surgical intervention when necessary play an important role in improving respiratory flow.
Nasal Congestion
Nasal congestion can contribute to the development of hypopnea by causing a decrease in airflow during sleep. The narrowing of the nasal passage leads the person to breathe through the mouth and results in increased resistance in the upper airway. This situation can cause shallow breathing, snoring, and fluctuations in oxygen levels. Allergic rhinitis, chronic sinusitis, enlarged nasal turbinates (conchae), and a deviated septum are frequent causes of nasal congestion. Congestion that increases especially at night can disrupt sleep quality, leading to frequent micro-arousals and waking up unrefreshed.
When nasal congestion persists for a long time, it can cause an increase in negative pressure in the upper airway, laying the groundwork for the airway to narrow more easily. Especially in individuals with pre-existing anatomical predisposition, this situation can increase the frequency of hypopnea and obstructive respiratory events. Opening the nasal passage through appropriate medical treatment (allergy management, nasal sprays, etc.) or surgical intervention when necessary can improve nighttime breathing quality and reduce sleep fragmentation.
Genetic Factors
Genetic factors can play an important role in the development of hypopnea and sleep-related breathing disorders. It is known that the risk is higher in individuals with a family history of sleep apnea. Structural features affecting the upper airway, particularly jaw structure, facial bone shape, tongue and soft palate anatomy, can be hereditary. These anatomical predispositions can lay the groundwork for the airway to narrow more easily and breathing to become shallow during sleep.
In addition, genetic factors can affect not only anatomical structure, but also respiratory control mechanisms and fat distribution. Characteristics such as predisposition to obesity, differences in muscle tone, and the sensitivity of the respiratory center to carbon dioxide may also include hereditary components. Therefore, evaluating symptoms in the early period in individuals with a family history is important in terms of detecting potential sleep disorders in a timely manner.
Alcohol and Cigarette Use
Alcohol consumption can cause the upper airway to narrow more easily by reducing muscle tone during sleep. Alcohol consumed especially before bedtime increases the relaxation of throat muscles and raises airway resistance. This situation can increase the frequency and duration of hypopnea attacks, making oxygen drops more pronounced. Furthermore, alcohol can lead to shallower and fragmented sleep by disrupting sleep architecture.
Cigarette use, on the other hand, can narrow the air passage by causing chronic inflammation and mucosal edema formation in the respiratory tracts. Long-term cigarette consumption leads to structural changes in the nose and upper airway, increasing respiratory resistance. This lays the groundwork for a decrease in airflow and an increase in hypopnea events during sleep. Quitting alcohol and cigarettes is an important step in terms of improving both general health and sleep quality.
Neurological Causes
Neurological causes are rarer but clinically significant reasons for hypopnea. The respiratory centers located in the brainstem are responsible for the automatic regulation of breathing. Strokes, tumors, trauma, or degenerative diseases affecting these regions can disrupt respiratory control, leading to a decrease in respiratory depth. In this case, even if the airway is open, hypopnea attacks can develop because the brain cannot send sufficient and regular signals to the respiratory muscles.
Additionally, neurological diseases such as Parkinson's disease, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) can also affect the coordination of respiratory muscles. A weakening of the respiratory center's response to carbon dioxide can cause ventilation to become shallow during sleep. Therefore, sleep quality and nighttime breathing patterns must be carefully evaluated in individuals with neurological diseases.
The Relationship Between Hypopnea and Sleep Apnea
Hypopnea and sleep apnea are closely related concepts and are generally evaluated together. While sleep apnea refers to the general picture where breathing is recurrently disrupted during sleep, these disruptions can manifest as apnea (complete stoppage) and hypopnea (partial reduction). In other words, hypopnea is a component of the sleep apnea syndrome. During a sleep study, both events are counted together to calculate the Apnea-Hypopnea Index (AHI), and the severity of the disease is determined based on this total value.
Although hypopnea may clinically appear milder than apnea, when it recurs frequently, it can produce similar physiological effects. Recurrent oxygen drops and micro-arousals can disrupt sleep integrity, leading to excessive daytime sleepiness, decreased attention, and an increased cardiovascular stress load. Therefore, not only complete respiratory stoppages, but also partial reductions carry great importance in diagnosis and treatment planning.
How is Hypopnea Diagnosed?
The diagnosis of hypopnea is established through the evaluation of the patient's clinical complaints and objective sleep studies. In the presence of symptoms such as waking up tired in the morning, excessive daytime sleepiness, snoring, and lack of attention, a suspicion of a sleep-related breathing disorder arises. However, symptoms alone are not sufficient for a definitive diagnosis; respiratory events must be measured.
The gold standard method in diagnosis is known as polysomnography (nighttime sleep study). During this test, airflow, respiratory movements, oxygen saturation, heart rhythm, and brain waves are recorded. Hypopnea is typically detected as a respiratory event lasting at least 10 seconds, accompanied by a specific percentage decrease in airflow along with an oxygen drop or micro-arousal. The obtained data is used in the calculation of the Apnea-Hypopnea Index (AHI), and the severity of the disease is determined accordingly.
Hypopnea Treatment
Hypopnea treatment is planned according to the underlying cause and the severity of the respiratory events. The most frequently preferred method is positive airway pressure devices. CPAP treatment, in particular, helps keep the airway open during sleep, preventing breathing from becoming shallow and assisting in maintaining balanced oxygen levels.
With appropriate pressure settings, hypopnea attacks can be significantly reduced, and sleep quality can be improved.
Alongside this, lifestyle changes such as weight control, reducing alcohol consumption, quitting smoking, and regulating the sleeping position support treatment. If there are structural problems such as nasal congestion or anatomical strictures, medical or surgical options can be evaluated. The treatment plan must be prepared specifically for the individual and its effectiveness evaluated through regular follow-up; thus, both nighttime breathing quality increases and daytime life performance improves.
CPAP Device
CPAP (Continuous Positive Airway Pressure) is a respiratory support device that delivers air at a continuous and constant pressure to ensure the airway remains open during sleep. Positive pressure applied via a mask prevents the upper airway from narrowing, thereby reducing apnea and hypopnea attacks. It is considered the first-line method, particularly in the treatment of obstructive sleep apnea and hypopnea. When used regularly and correctly, it balances oxygen levels, reduces nighttime awakenings, and helps correct excessive daytime sleepiness. The effectiveness of the device can be increased with proper mask selection and personalized pressure settings.
For CPAP treatment to be successful, it is important that the device is used every night and for a sufficient duration. An adjustment period to the mask may be experienced during the first few days; however, choosing the right mask type and using a humidifier can increase comfort. With regular use, snoring decreases, hypopnea and apnea attacks are brought under control, and sleep integrity improves. Furthermore, adherence to treatment contributes to reducing long-term cardiovascular risks and increasing overall quality of life.
Weight Loss
Weight loss is an important and supportive approach in the treatment of hypopnea and obstructive sleep apnea. Specifically, the reduction of adipose tissue around the neck and upper airway helps the airway remain more open during sleep. Additionally, the decrease in abdominal fat accumulation eases diaphragmatic movements and positively affects lung capacity. Studies show that controlled reductions in body weight can provide a decrease in Apnea-Hypopnea Index (AHI) values. Weight loss achieved through a balanced diet and regular physical activity contributes to improving both respiratory quality and general health status.
Weight control also contributes to a reduction in blood pressure, insulin resistance, and cardiovascular risk factors; this situation can mitigate the negative effects of oxygen fluctuations occurring during sleep on the body. Especially in individuals experiencing obesity-related hypopnea, a sustainable weight loss process planned under physician supervision can increase treatment success. While weight loss can significantly reduce respiratory events in some patients, more effective results can be obtained when applied together with device therapy in advanced cases.
Oral Appliances
Oral appliances are alternative treatment options used particularly in mild and moderate hypopnea or obstructive sleep apnea cases. These custom devices position the lower jaw slightly forward, preventing the tongue base from falling backward and ensuring the upper airway remains more open. Thus, airflow increases during sleep, and the shallowness of breathing may decrease. They are generally prepared by a dentist by taking personalized measurements and require regular use.
These appliances can be a suitable option for patients who cannot adapt to the CPAP device or who have a milder level of breathing disorder. Proper patient selection and regular follow-up are important in terms of treatment success. Temporary side effects such as jaw pain, dental sensitivity, or increased saliva may be observed in some individuals; however, with appropriate adjustments, these issues can generally be brought under control.
Surgical Intervention
Surgical intervention is an option evaluated in cases of hypopnea and obstructive sleep apnea where the underlying anatomical narrowing is pronounced and sufficient benefit cannot be obtained from other treatment methods. The aim is to increase airflow by removing structural obstacles in the upper airway. Problems such as large tonsils and adenoids, soft palate sagging, a deviated nasal septum, or narrowing due to jaw structure can be corrected with surgery. Proper patient selection is of great importance in terms of success rate.
Surgical options are planned individually and evaluated by ear, nose, and throat or jaw surgery specialists. They may not provide a definitive standalone solution in every patient; in some cases, additional treatments may be needed post-surgery. Therefore, the decision for surgery should be made after sleep test results and a comprehensive clinical evaluation. When applied with the correct indication, it can improve respiratory quality by increasing airway patency.
Lifestyle Changes
Lifestyle changes play an important supportive role in the management of hypopnea and sleep-related breathing disorders. Establishing regular sleep hours, maintaining an ideal weight, and eating a balanced diet specifically contribute to the respiratory system functioning more healthily. Limiting alcohol consumption and avoiding sedative substances before bedtime can help preserve upper airway muscle tone. Additionally, regular physical activity both supports weight control and improves cardiovascular health.
Regulating the sleep position is also an important factor; since sleeping supine can increase airway narrowing in some individuals, sleeping in a lateral position may be recommended. Quitting smoking can improve airflow by reducing inflammation in the upper airway. Although these changes alone may not be sufficient in advanced cases, when applied together with medical or device treatments, they enhance treatment success and can significantly improve sleep quality in the long term.
Is Hypopnea Dangerous?
Because hypopnea occurs as a reduction in breathing rather than a complete cessation, it can be perceived as a mild condition; however, when it recurs frequently, it can create serious health effects. Oxygen drops occurring during sleep and recurring micro-arousals can disrupt sleep integrity, leading to chronic fatigue, decreased attention, and excessive daytime sleepiness. This situation can significantly affect the quality of life.
In the long term, untreated and high-frequency hypopnea events can place an additional load on the cardiovascular system. Oxygen fluctuations can contribute to irregularities in heart rhythm, blood pressure changes, and an increase in metabolic stress. Therefore, an appropriate evaluation and treatment planning are important, especially in the presence of moderate-to-severe hypopnea. With early diagnosis, risks can be reduced, and sleep quality can be significantly improved.
At What Level Is Hypopnea Risky?
The risk level of hypopnea is evaluated not by its count alone, but according to the Apnea-Hypopnea Index (AHI) value, which indicates the total number of apnea and hypopnea events per hour. An AHI value below 5 is generally considered normal. Between 5 and 15 per hour is classified as mild, 15 to 30 as moderate, and above 30 as severe sleep-related breathing disorder. Risk increases along with the rise of this value.
However, not only the number, but also the degree of oxygen drop and the patient's clinical symptoms are important. If there is marked oxygen desaturation or excessive daytime sleepiness despite a low AHI value, clinical risk may increase. Careful evaluation is required even at lower thresholds, especially in individuals with heart disease, hypertension, or metabolic disease. Therefore, risk assessment must definitely be made by considering sleep test results and the clinical picture together.
Is Hypopnea Seen in Children?
Yes, hypopnea can also be seen in children and generally emerges as part of the obstructive sleep apnea picture. The most frequent cause in children is enlarged tonsils and adenoids. This condition, which leads to the narrowing of the upper airway, can cause breathing to become shallow during sleep and a drop in oxygen levels. Snoring, sleeping with an open mouth, restless sleep, and night sweats are among the prominent symptoms in children.
Hypopnea in children can affect not only sleep quality, but also growth and development. Sleep fragmented throughout the night can manifest itself with symptoms such as attention deficit, learning difficulties, behavioral problems, and daytime hyperactivity. Therefore, it is important that children who snore frequently, have irregular breathing during sleep, or whose daytime performance is affected undergo a pediatric evaluation. With early diagnosis and appropriate treatment, both sleep patterns and general development can be positively supported.